glp-1/gip dual agonist lilly orforglipron oral GLP-1 phase 3 weight loss trial Day 1: Injectables vs. Orals

Patients in this program can be tested at MSKCC but treated elsewhere if needed

Exercise optimization during combination therapy The right exercise approach amplifies the effects of both compounds while protecting lean mass

Biochemical Identity and Properties of BPC-157 BPC-157, a pentadecapeptide consisting of 15 amino acids, originates from a larger protein sequence identified in gastric juice

High GLP-1 release following mealtimes can lead to: Insulin Release: GLP-1 signals to the pancreas to increase insulin release following a meal, which can balance blood sugar levels

This comprehensive review brings together multiple lines of evidence for the dysfunction of the glutamate system in mood disorders, including genetic, post-mortem and in vivo neuroimaging data